mirtazapine has been researched along with Rheumatoid Arthritis in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishigori, R | 1 |
| Warabi, Y | 1 |
| Shishido-Hara, Y | 1 |
| Nakamichi, K | 1 |
| Nakata, Y | 1 |
| Komori, T | 1 |
| Isozaki, E | 1 |
1 other study available for mirtazapine and Rheumatoid Arthritis
| Article | Year |
|---|---|
Inflammatory Cerebellar PML with a CD4/CD8 Ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis.
Topics: Aged; Antimalarials; Arthritis, Rheumatoid; Brain; CD4-CD8 Ratio; Cerebellum; Female; Humans; Immuno | 2019 |